#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The Impact of Different Rocuronium Doses on its Pharmacodynamic Profile:a Prospective Study


Authors: M. Adamus 1;  R. Bělohlávek 2;  M. Vujčíková 1;  E. Janásková 1
Authors‘ workplace: Klinika anesteziologie a resuscitace, Fakultní nemocnice a Lékařská fakulta Univerzity Palackého, Olomouc 2Katedra matematické informatiky, Přírodovědecká fakulta Univerzity Palackého, Olomouc 1
Published in: Anest. intenziv. Med., , 2004, č. 6, s. 269-275
Category:

Overview

Objective:
The aim of the study was to assess rocuronium pharmacodynamics following a single bolus dose.Design: Clinical prospective randomized controlled study.Setting: Department of Anaesthesiology and Intensive Care, University Hospital.Material and Methods: Following the ethics committee approval and obtaining informed consent 210 patients scheduled forelective surgery under general anaesthesia with tracheal intubation were randomized into 7 groups with different rocuroniumdoses administered (0.30, 0.45, 0.60, 0.75, 0.90, 1.05, 1.20 mg•kg-1, respectively). After setting up neuromusculartransmission monitoring (Datex-Ohmeda S5 Anaesthesia Monitor with NMT module, ulnar nerve stimulation, TOF pattern,electromyographic evaluation of evoked response of the adductor pollicis muscle), tracheal intubation was performed after80%depression of T1. For each consecutive patient the onset time for 80 (95) % effect, clinical duration and recovery indexwere determined. The recorded data were subjected to statistical analysis.Results: The onset time 80 was 123.3 ± 15.4, 94.7 ± 14.6, 71.3 ± 12.9, 59.2 ± 10.6, 54.7 ± 8.4, 50.8 ± 8.0, 47.0 ± 8.1 seconds,respectively, the onset time 95 was 162.8 ± 14.7, 119.3 ± 13.4, 92.8 ± 13.0, 82.0 ± 16.3, 74.5 ± 13.6, 67.2 ± 12.3, 63.2 ± 9.6seconds. The clinical duration was 15.0 ± 3.7, 23.4 ± 3.8, 35.6 ± 6.1, 45.5 ± 6.6, 53.5 ± 10.5, 62.8 ± 13.1, 70.6 ± 15.0 minutes.The recovery index was 12.5 ± 3.9, 13.3 ± 4.3, 14.9 ± 3.8, 17.9 ± 3.8, 18.5 ± 4.6, 18.8 ± 5.6, 19.9 ± 5.8 minutes. When 80 %depression of T1 was reached the quality of intubating conditions was the same in all groups.Conclusion: Rocuronium is a rapid-onset neuromuscular blocker with a predictable effect. By decreasing the intubatingdose by 50 % the clinical duration is shortened by more than 50 %. If we accept the simultaneous onset time prolongationduring this anaesthetic strategy a low-dose rocuronium can be used for the neuromuscular block of about 15-minuteduration. However, comparable intubating conditions (as assesed from NMT measurements and the clinical picture) arereached after two or more minutes.

Key words:
neuromuscular blocker – rocuronium – onset time – clinical duration – recovery index

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Anaesthesiology, Resuscitation and Inten Intensive Care Medicine
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#